Rheumatoid Arthritis Archives - Medical Conferences

New JAK1 inhibitor outperforms placebo in active RA

Presented By

Dr Jinjing Liu, Peking Union Medical College Hospital, China

Trial

Phase 3

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:37

Macrophage profiling in synovial tissue predicts treatment response in RA

Presented By

Dr Simone Perniola, Policlinico Universitario A. Gemelli IRCS, Italy

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:36

Innovative app boosts mental health in patients with RA

Presented By

Prof. Frank Behrens, Goethe-University & Fraunhofer ITMP, Germany

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:35

Stopping DMARDs? These key factors predict RA flares

Presented By

Dr Fiona Rayner, Newcastle University, UK

Trial

BIO-FLARE

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:27

Improving outcomes in pregnancy and psoriatic disease

Presented By

Dr Oseme Etomi, Guy's and St Thomas' Hospital, UK

Conference

IFPA 2024

Type

News article

17 July 2024 13:44

Interview: Medicare’s first drug price negotiations: concerning?

Expert

Prof. Marc Bonaca, University of Colorado, USA

4 January 2024 15:06

Short-term glucocorticoid use increases the risk of MACE

Presented By

Dr Beth Wallace, University of Michigan, MI, USA

Conference

ACR 2023

Type

News article

1 December 2023 12:32

Baricitinib superior to TNFi in patients with RA who failed csDMARDs

Presented By

Dr Mart van der Laar, University of Twente, The Netherlands

Trial

PerfectRA

Conference

ACR 2023

Type

News article

1 December 2023 11:40

Therapy with biological DMARDs shows no correlation with fracture risk in RA

Presented By

Ms Ingebjorg Tronstad, Norwegian University of Science and Technology, Norway

Trial

HUNT

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:50

Poly-refractory RA: not common, but still present

Presented By

Dr Paula David, University of Leeds, UK

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:04

COBRA-Slim bio-induction: no benefit compared with the standard regimen

Trial

CareRA2020

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:59

AI almost as successful as experts in predicting early RA

Presented By

Dr Yanli Li, Leiden University Center, the Netherlands

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:54

Disease activity-guided dose reduction may be a long-term option for stable RA

Presented By

Dr Noortje van Herwaarden, Sint Maartenskliniek, the Netherlands

Trial

DRESS

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:40

Cardiovascular safety of JAK inhibitors: reassuring results from a real-world study

Presented By

Mr Romain Aymon, Geneva University Hospital, Switzerland

Trial

ORAL Surveillance

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 00:00

Selective JAK1/TYK 2 inhibitor effective in patients with difficult-to-treat RA

Presented By

Prof. Xiaofeng Zeng, Peking Union Medical College Hospital, China

Conference

EULAR 2023

Type

Peer-reviewed article

30 July 2023 23:53

Stimulation of PD-1: a new concept to treat RA

Presented By

Prof. Paul Emery, University of Leeds, UK

Trial

Phase 2

Conference

ACR 2022

Type

News article

1 December 2022 14:28

High retention rates after switching between infliximab biosimilars

Presented By

Dr Hafsah Nabi, Rigshospitalet, Denmar

Conference

ACR 2022

Type

News article

1 December 2022 14:21

New analysis assesses the safety of tofacitinib regarding extended MACE

Presented By

Prof. Maya Buch, University of Manchester, United Kingdom

Trial

ORAL Surveillance

Conference

ACR 2022

Type

News article

1 December 2022 14:18

Lack of vaccination results in a higher frequency of pre-term births in pregnant women with rheumatic disease and COVID-19

Presented By

Dr Sinead Magui, St. James’ Hospital, Ireland

Conference

ACR 2022

Type

News article

1 December 2022 14:12

Early treatment: a key to improved outcomes in polyarticular JIA

Presented By

Prof. Yukiko Kimura, Hackensack Meridian School of Medicine, USA

Trial

STOP-JIA

Conference

ACR 2022

Type

News article

1 December 2022 12:23

No increased cancer risk in patients with rheumatic diseases and prior malignancy treated with novel therapies

Presented By

Dr Juan Molina Collada , Gregorio Marañón General University Hospital, Spain

Trial

BIOBADASER

Conference

ACR 2022

Type

News article

1 December 2022 12:03

Antifibrotic therapy may slow down FVC decline in RAILD

Presented By

Prof. Ivan Rosas, Baylor College of Medicine, TX, USA

Trial

Phase 2, TRAIL1

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 22:11

Alarmingly low activity in patients with non-inflammatory and inflammatory rheumatic disease

Presented By

Prof. Luca Quartuccio, University of Udine, Italy

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 19:31

Many RA and PsA patients have problems with their sex life

Presented By

Dr Carlos Valera-Ribera , Doctor Peset University Hospital, Spain

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:12

Comorbid depression comes with a profoundly higher mortality risk in RA

Presented By

Dr Jens Kristian Pedersen, Odense University Hospital, Denmark

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 15:10

Preventive treatment with methotrexate benefits pre-RA patients with arthralgia

Presented By

Dr Doortje Krijbolder, Leiden University Medical Center, the Netherlands

Trial

TREAT EARLIER

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 15:07

Risk factors for dementia in RA patients discovered

Presented By

Prof. Elena Myasoedova , Mayo Clinic, MN, USA

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 15:02

VTE in global registry data more common in JAK inhibitor-treated RA patients

Presented By

Prof. Adeline Ruyssen-Witrand, Toulouse University Hospital, France

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 14:52

JAK inhibitors: A risk assessment

Presented By

Prof. Brett King, Yale School of Medicine, USA

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 10:59

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By

Dr Ali Al-Janabi, University of Manchester, UK

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 15:22

Cycling JAK inhibitors shows similar effectiveness to switching to a bDMARD in difficult-to-treat RA

Presented By

Dr Manuel Pombo-Suarez, Hospital Clinico Universitario de Santiago De Compostela, Spain

Trial

JAK-pot

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 11:03

Pre-existing heart failure affects safety of hydroxychloroquine in RA patients

Presented By

Dr Elvira D’Andrea, Brigham and Women’s Hospital, MA, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 11:01

Patients with RA-associated interstitial lung disease benefit from antifibrotic agent

Presented By

Prof. Joshua J. Solomon, National Jewish Health, CO, USA

Trial

Phase 2, TRAIL1

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:59

Ultra-low dosing of rituximab in RA is a viable treatment option

Presented By

Mr Nathan den Broeder, Sint Maartenskliniek, the Netherlands

Trial

REDO

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:58

Kidney disease and hydroxychloroquine dose are risk factors for developing retinopathy

Presented By

Dr April Jorge, Massachusetts General Hospital, MA, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:55

More pros than cons for the use of statins in RA

Presented By

Dr Gulsen Ozen, University of Nebraska Medical Center, NE, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:54

Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections

Presented By

Prof. Jasvinder Singh, University of Alabama at Birmingham, AL, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:47

B-cell depleting medication increases COVID-19 breakthrough infection outcome risk

Presented By

Prof. Jean Liew, Boston University, MA, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:45

COVID-19 mRNA vaccine safe and tolerable in adults with autoimmune disease

Presented By

Dr Inés Colmegna, McGill University Health Centre, Canada

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:06

ACR 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ACR 2021

22 November 2021 16:18

Remote management of RA is a feasible alternative for outpatient follow-up

Presented By

Dr Mwidimi Ndosi, University of the West of England, UK

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 22:57

Fenebrutinib at highest dose generally well tolerated

Conference

AAN 2021

Type

Peer-reviewed article

16 June 2021 11:49

Preliminary findings suggest rozibafusp alfa effective and tolerable in RA

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 09:56

Immune-related AEs due to checkpoint inhibitors require care coordination

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 09:49

New nanoparticle promising future agent in RA

Presented By

Prof. Kira Astakhova, Technical University of Denmark, Denmark

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 09:43

Olokizumab significantly improves RA features and patient-reported outcomes

Presented By

Prof. Rumen Stoilov, University Hospital St. Ivan Rilski, Bulgaria

Trial

CREDO-1

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 09:33

Low DAS at 4 months predicts sustained DMARD-free remission

Presented By

Ms Marloes Verstappen, Leiden University Medical Center, the Netherlands

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 07:50

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By

Dr Evelyne Vinet, McGill University, Montreal, Canada

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:12

Filgotinib promising in RA patients naïve to methotrexate

Presented By

Prof. Rene Westhovens, University of Leuven, Belgium

Trial

Phase 3, FINCH 3

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:05

Sustained efficacy of monotherapy with upadacitinib after 48 weeks

Presented By

Prof. Joseph Smolen, Medical University of Vienna, Austria

Trial

SELECT-MONOTHERAPY

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 22:06

Proteome abnormalities improve prediction of RA development

Presented By

Dr Liam O´Neil, University of Manitoba, Canada

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 21:47

Biologics show similar activity in patients with elderly-onset RA

Presented By

Dr Sadao Jinno, Kobe University School of Medicine, Japan

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 21:08

RA patients in remission benefit from continued therapy with conventional DMARDs

Presented By

Dr Siri Lillegraven, Diakonhjemmet Hospital,Norway

Trial

ARCTIC REWIND, TARA

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 20:51

Tocilizumab outperforms rituximab in RA patients with low level of synovial B cell infiltration

Presented By

Prof. Costantino Pitzalis, Barts and The London School of Medicine and Dentistry, UK

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 20:10

Treatment decisions should not be guided by ultrasound findings

Presented By

Dr Espen Haavardsholm, Diakonhjemmet Hospital, Oslo, Norway

Trial

ARCTIC, TaSER

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 19:11

Cancer treatment with checkpoint inhibitors in RA patients?

Presented By

Dr Sabina Sandigursky, New York University Langone Medical Center, USA

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 11:13

TNFi for RA during pregnancy – to stop or not to stop?

Presented By

Dr Isabell Haase, Heinrich-Heine University Düsseldorf, Germany

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 10:16

Cohort study shows improvement during 25 years of RA treatment

Presented By

Dr Xanthe Matthijssen, Leiden University Medical Center, the Netherlands

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 23:13

Filgotinib in RA patients with inadequate response or naïve to methotrexate

Presented By

Prof. Rene Westhovens, University Hospital Leuven, Belgium

Trial

Phase 3, FINCH-3

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 22:35

Clinical effectiveness of fenebrutinib in RA patients with methotrexate or TNFi failure

Presented By

Dr Stanley Cohen, Metroplex Clinical Research Center, Dallas, USA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 21:38

Peficitinib likely efficacious and safe

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 20:42

Short methotrexate stop is safe in patients with RA

Presented By

Dr Min Jung Kim, Seoul National University Hospital, South Korea

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 19:47

Tofacitinib is safe according to real-world data analysis

Presented By

Dr Joel Kremer, Albany Medical College, New York, USA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 18:51

Switching upadacitinib and adalimumab is beneficial in refractory RA

Trial

Phase 3, SELECT-COMPARE

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 17:54

Tapering of prednisone in RA patients who achieved low disease activity or remission with tocilizumab

Presented By

Prof. Gerd Burmester, Free University and Humboldt University of Berlin, Germany

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 16:56

Efficacy and safety of E6011 in RA patients with inadequate response to methotrexate

Presented By

Dr Yoshiya Tanaka, University of Occupational and Environmental Health, Japan

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 15:58

Preliminary efficacy and safety data of RG6125 in RA patients with an inadequate response to TNF inhibitors

Presented By

Uwe Junker, Roche Innovation Center Basel, Switzerland

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 14:01

Integrated 10-year analysis confirms safety profile abatacept

Presented By

Dr Teresa Simon, Bristol-Myers Squibb, USA

Trial

Cohort study, ARTIS, RABBIT, FORWARD, British Columbia Canadian RA Cohort

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 13:03

Switching among multiple infliximab biosimilars does not cause immunogenicity

Presented By

Dr Jéróme Avouac, Paris Descartes University, France

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 12:06

NSAIDs consumption is linked to patient-assessed disease activity and decreases with use of TNF inhibitors

Presented By

Dr Olafur Palsson, University Hospital Reykjavik, Iceland

Trial

ICEBIO database

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:11

IBD risk of treatment with IL-17 antagonists

Presented By

Dr Wolfgang Eigner, Medical University of Vienna, Austria

Conference

ECCO 2019

Type

Peer-reviewed article

9 May 2019 14:37

Psoriasis and Biologics: The Beat Goes On

Presented By

Prof. Mark Lebwohl, Mount Sinai School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:06

Biologic drug levels and infection risk, and clinical effectiveness of sarilumab

Trial

TARGET

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 19:30

Confirmation of long-term safety profile adalimumab across indications

Presented By

Prof. Gerd Burmester, Charité University Hospital, Free University and Humboldt University of Berlin, Germany

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 18:39